HomeGANX • NASDAQ
add
Gain Therapeutics Inc
Previous close
$3.06
Day range
$2.92 - $3.37
Year range
$1.41 - $3.65
Market cap
127.69M USD
Avg Volume
1.08M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.98M | 5.58% |
Net income | -5.28M | -17.81% |
Net profit margin | — | — |
Earnings per share | -0.15 | 11.76% |
EBITDA | -4.78M | -7.39% |
Effective tax rate | -11.60% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.81M | -26.91% |
Total assets | 10.97M | -23.63% |
Total liabilities | 5.06M | -7.22% |
Total equity | 5.91M | — |
Shares outstanding | 36.10M | — |
Price to book | 19.12 | — |
Return on assets | -115.14% | — |
Return on capital | -219.94% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.28M | -17.81% |
Cash from operations | -4.93M | 18.92% |
Cash from investing | — | — |
Cash from financing | 7.03M | 769.67% |
Net change in cash | 2.11M | 143.26% |
Free cash flow | -2.61M | 40.93% |
About
Founded
2017
Website
Employees
24
